Dr. Tyler Lee Bloomer, MD

Dr. Bloomer practices at Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources.

Dr. Bloomer's NPI, 1306104765, was assigned on April 23, 2012. Dr. Bloomer graduated from Joe R. & Teresa Lozano Long School of Medicine in 2012. Dr. Bloomer holds Texas license R9719.

Dr. Bloomer's primary practice is Texas Health Fort Worth, at 1301 Pennsylvania Avenue, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 250-2100.

Dr. Bloomer's primary practice is Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources. Dr. Bloomer is also affiliated with Texas Health Southwest Fort Worth. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Bloomer to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bloomer practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Bloomer's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Bloomer is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Bloomer's licenses on file in 2 states: Texas and Tennessee.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Bloomer treats.

CMS data shows 1,836 Medicare services from Dr. Bloomer across 24 procedure codes in 2024, for 523 Medicare patients. Medicare paid $127,831 for them.

CMS counts 523 Medicare patients who saw Dr. Bloomer in 2024. The largest group is 65 to 74, with 227 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bloomer's median patient age at 69, with 47% women.

In 2024, Dr. Bloomer wrote 2,544 Medicare Part D claims for 363 patients. 77% of them were for generic drugs. CMS names the drug for 2,385 of them, across 28 drugs with 11 or more claims each, at $530,217 in total drug cost. In 2023, CMS named 1,828 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Bloomer for performance year 2024, reported individually. Dr. Bloomer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 41 procedures of coronary angioplasty and stenting by Dr. Bloomer, more than 77% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Bloomer, published from 2016 to 2017. 2016 was the busiest year, with 2. The most frequent topics are Pulmonary Embolism and Thrombolytic Therapy. Dr. Bloomer's most frequent co-authors are Pete Pitaya Fong, MD, Javid J. Moslehi, MD and Matthew Alexander, MD, PhD.

CMS Open Payments shows 149 general payments to Dr. Bloomer from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $3,864. It also lists 1 research payment totaling $21,385 in 2024.

Dr. Bloomer graduated from Joe R. & Teresa Lozano Long School of Medicine in 2012.

Dr. Bloomer is in network with 21 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.